About
We pioneer immunotherapy for infections, innovating clinical trials and advancing host-directed medicine. We enhance understanding of host biology, aiming to transform therapy and improve patient outcomes globally.
Research group leader
prof. dr. Frank van de Veerdonk
Research programs
Programs that are connected to this research group.